Stock Screener · Library
Corvus Pharmaceuticals, Inc. financial statement history
Source-linked financial facts for Corvus Pharmaceuticals, Inc. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 109455000 | USD | 2023-03-28 | 2021 / FY | us-gaap:Assets | 10-K · 0001558370-23-004792 |
| As of 2022-12-31 | 68240000 | USD | 2024-03-19 | 2023 / FY | us-gaap:Assets | 10-K · 0001558370-24-003567 |
| As of 2023-12-31 | 45553000 | USD | 2025-03-25 | 2024 / FY | us-gaap:Assets | 10-K · 0001558370-25-003621 |
| As of 2024-12-31 | 68907000 | USD | 2026-03-12 | 2025 / FY | us-gaap:Assets | 10-K · 0001104659-26-027047 |
| As of 2025-12-31 | 71119000 | USD | 2026-03-12 | 2025 / FY | us-gaap:Assets | 10-K · 0001104659-26-027047 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 71312000 | USD | 2023-03-28 | 2021 / FY | us-gaap:AssetsCurrent | 10-K · 0001558370-23-004792 |
| As of 2022-12-31 | 43664000 | USD | 2024-03-19 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001558370-24-003567 |
| As of 2023-12-31 | 27956000 | USD | 2025-03-25 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001558370-25-003621 |
| As of 2024-12-31 | 54407000 | USD | 2026-03-12 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001104659-26-027047 |
| As of 2025-12-31 | 58214000 | USD | 2026-03-12 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001104659-26-027047 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 63458000 | USD | 2023-03-28 | 2021 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001558370-23-004792 |
| As of 2022-12-31 | 13159000 | USD | 2024-03-19 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001558370-24-003567 |
| As of 2023-12-31 | 12620000 | USD | 2025-03-25 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001558370-25-003621 |
| As of 2024-12-31 | 8740000 | USD | 2026-03-12 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001104659-26-027047 |
| As of 2025-12-31 | 4576000 | USD | 2026-03-12 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001104659-26-027047 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 451000 | USD | 2023-03-28 | 2021 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001558370-23-004792 |
| As of 2022-12-31 | 353000 | USD | 2024-03-19 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001558370-24-003567 |
| As of 2023-12-31 | 236000 | USD | 2025-03-25 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001558370-25-003621 |
| As of 2024-12-31 | 151000 | USD | 2026-03-12 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001104659-26-027047 |
| As of 2025-12-31 | 220000 | USD | 2026-03-12 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001104659-26-027047 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 12293000 | USD | 2023-03-28 | 2021 / FY | us-gaap:Liabilities | 10-K · 0001558370-23-004792 |
| As of 2022-12-31 | 12125000 | USD | 2024-03-19 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001558370-24-003567 |
| As of 2023-12-31 | 6869000 | USD | 2025-03-25 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001558370-25-003621 |
| As of 2024-12-31 | 36339000 | USD | 2026-03-12 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001104659-26-027047 |
| As of 2025-12-31 | 9914000 | USD | 2026-03-12 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001104659-26-027047 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 9692000 | USD | 2023-03-28 | 2021 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001558370-23-004792 |
| As of 2022-12-31 | 10752000 | USD | 2024-03-19 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001558370-24-003567 |
| As of 2023-12-31 | 6869000 | USD | 2025-03-25 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001558370-25-003621 |
| As of 2024-12-31 | 35402000 | USD | 2026-03-12 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001104659-26-027047 |
| As of 2025-12-31 | 9380000 | USD | 2026-03-12 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001104659-26-027047 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 97162000 | USD | 2025-03-25 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001558370-25-003621 |
| As of 2022-12-31 | 56115000 | USD | 2026-03-12 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001104659-26-027047 |
| As of 2023-12-31 | 38684000 | USD | 2026-03-12 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001104659-26-027047 |
| As of 2024-12-31 | 32568000 | USD | 2026-03-12 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001104659-26-027047 |
| As of 2025-12-31 | 61205000 | USD | 2026-03-12 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001104659-26-027047 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 29115000 | USD | 2024-03-19 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001558370-24-003567 |
| 2022-01-01 to 2022-12-31 | 24468000 | USD | 2025-03-25 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001558370-25-003621 |
| 2023-01-01 to 2023-12-31 | 16526000 | USD | 2026-03-12 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001104659-26-027047 |
| 2024-01-01 to 2024-12-31 | 19385000 | USD | 2026-03-12 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001104659-26-027047 |
| 2025-01-01 to 2025-12-31 | 33719000 | USD | 2026-03-12 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001104659-26-027047 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -38630000 | USD | 2024-03-19 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001558370-24-003567 |
| 2022-01-01 to 2022-12-31 | -32565000 | USD | 2025-03-25 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001558370-25-003621 |
| 2023-01-01 to 2023-12-31 | -23407000 | USD | 2026-03-12 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001104659-26-027047 |
| 2024-01-01 to 2024-12-31 | -27548000 | USD | 2026-03-12 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001104659-26-027047 |
| 2025-01-01 to 2025-12-31 | -42971000 | USD | 2026-03-12 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001104659-26-027047 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -43241000 | USD | 2024-03-19 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0001558370-24-003567 |
| 2022-01-01 to 2022-12-31 | -41307000 | USD | 2025-03-25 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001558370-25-003621 |
| 2023-01-01 to 2023-12-31 | -27029000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001104659-26-027047 |
| 2024-01-01 to 2024-12-31 | -62293000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001104659-26-027047 |
| 2025-01-01 to 2025-12-31 | -15283000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001104659-26-027047 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -1.03 | USD/shares | 2024-03-19 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001558370-24-003567 |
| 2022-01-01 to 2022-12-31 | -0.89 | USD/shares | 2025-03-25 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001558370-25-003621 |
| 2023-01-01 to 2023-12-31 | -0.56 | USD/shares | 2026-03-12 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001104659-26-027047 |
| 2024-01-01 to 2024-12-31 | -1.02 | USD/shares | 2026-03-12 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001104659-26-027047 |
| 2025-01-01 to 2025-12-31 | -0.53 | USD/shares | 2026-03-12 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001104659-26-027047 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -36715000 | USD | 2024-03-19 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001558370-24-003567 |
| 2022-01-01 to 2022-12-31 | -27023000 | USD | 2025-03-25 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001558370-25-003621 |
| 2023-01-01 to 2023-12-31 | -23935000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001104659-26-027047 |
| 2024-01-01 to 2024-12-31 | -25424000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001104659-26-027047 |
| 2025-01-01 to 2025-12-31 | -32797000 | USD | 2026-03-12 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001104659-26-027047 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 5000 | USD | 2024-03-19 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001558370-24-003567 |
| 2022-01-01 to 2022-12-31 | 269000 | USD | 2025-03-25 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001558370-25-003621 |
| 2023-01-01 to 2023-12-31 | 34000 | USD | 2026-03-12 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001104659-26-027047 |
| 2025-01-01 to 2025-12-31 | 174000 | USD | 2026-03-12 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001104659-26-027047 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1626971
- Ticker in native snapshot
- CRVS
- Reported numeric facts
- 64
- Units present
- USD · USD/shares